M Victoria Milanés Selected Research

Morphine Dependence

3/2016	Regulation of dopaminergic markers expression in response to acute and chronic morphine and to morphine withdrawal.
7/2015	Dysregulation of dopaminergic regulatory mechanisms in the mesolimbic pathway induced by morphine and morphine withdrawal.
1/2013	Differential Changes in Expression of Stress- and Metabolic-Related Neuropeptides in the Rat Hypothalamus during Morphine Dependence and Withdrawal.
1/2012	Involvement of noradrenergic transmission in the PVN on CREB activation, TORC1 levels, and pituitary-adrenal axis activity during morphine withdrawal.
10/2009	Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus.
7/2009	Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal.
10/2008	Regulation of extracellular signal-regulated kinases (ERKs) by naloxone-induced morphine withdrawal in the brain stress system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Victoria Milanés Research Topics

Disease

7	Morphine Dependence 03/2016 - 10/2008
5	Substance-Related Disorders (Drug Abuse) 01/2019 - 10/2008
4	AIDS-Related Complex (ARC) 03/2022 - 12/2016
3	Pain (Aches) 02/2010 - 06/2005
2	Opioid-Related Disorders (Opiate Addiction) 01/2017 - 02/2003
2	Weight Loss (Weight Reduction) 01/2013 - 10/2010
2	Body Weight (Weight, Body) 01/2013 - 05/2010
1	Thymoma (Thymic Carcinoma) 01/2017
1	Medically Unexplained Symptoms 01/2012
1	Inflammation (Inflammations) 03/2009

Drug/Important Bio-Agent (IBA)

11	Morphine (MS Contin)FDA LinkGeneric 03/2022 - 02/2003
3	Opiate AlkaloidsIBA 03/2022 - 01/2012
3	Pharmaceutical PreparationsIBA 10/2017 - 10/2010
3	salicylhydroxamic acid (SHAM)IBA 10/2017 - 07/2009
2	Messenger RNA (mRNA)IBA 03/2022 - 12/2016
2	activity regulated cytoskeletal-associated proteinIBA 01/2019 - 10/2017
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017 - 10/2008
2	Proteins (Proteins, Gene)FDA Link 12/2016 - 07/2009
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 03/2016 - 07/2015
2	Naloxone (Narcan)FDA LinkGeneric 01/2013 - 05/2010
2	Opioid Analgesics (Opioids)IBA 03/2009 - 06/2005
1	GlucocorticoidsIBA 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2017
1	CytokinesIBA 01/2017
1	Protein Tyrosine PhosphatasesIBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 03/2016
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 03/2016
1	Cocaine (Cocaine HCl)IBA 01/2016
1	A-factor (Streptomyces)IBA 01/2016
1	ProlactinIBA 01/2013
1	CorticosteroneIBA 01/2013
1	NeuropeptidesIBA 01/2013
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2013
1	OrexinsIBA 01/2012
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2012
1	Prazosin (Minipress)FDA LinkGeneric 01/2012
1	Propranolol (Inderal)FDA LinkGeneric 01/2012
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2012
1	antalarminIBA 05/2010
1	CP 154526IBA 05/2010
1	Dynorphins (Dynorphin)IBA 02/2010
1	Cyclic AMP (AMP, Cyclic)IBA 10/2009
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 10/2009
1	Diazepam (Valium)FDA LinkGeneric 10/2009
1	Phosphodiesterase 4 InhibitorsIBA 10/2009
1	RolipramIBA 10/2009
1	Freund's AdjuvantIBA 03/2009
1	Analgesics (Analgesic Drugs)IBA 03/2009
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 02/2003

Therapy/Procedure

1	Therapeutics 06/2005